SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


National Association for Continuing Education
Faculty
Brad P. Glick, DO, MPH, FAOCD
Glick Skin Institute
Skin and Cancer Associates
Program Director - Dermatology Residency
Larkin Hospital - Palm Springs Campus
Clinical Assistant Professor of Dermatology
FIU Herbert Wertheim College of Medicine
Miami, Florida

Paul S. Yamauchi, MD, PhD
Dermatology Institute & Skin Care Center
Clinical Science Institute
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine at UCLA
Adjunct Associate Professor of Dermatology
John Wayne Cancer Institute
Santa Monica, CA

Course Director
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

Title
: Confronting Psoriatic Disease: Putting New Tools to Work
Activity/Course #:
: NCME348
Cost:
: Free
Release/Start Date:
: Mar 15 2018
Expiration Date:
: Mar 14 2019
Topics:
: Dermatology
Target Audience:
: Primary Care Providers
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s)
Hardware/Software Requirements:
Program Summary
Psoriasis is one of the most common chronic inflammatory T-cell-mediated autoimmune diseases, affecting as many as 7.5 million Americans - approximately 2.2% of the population. Skin disease is the most prominent feature of psoriasis and is characterized by thick, scaling red plaques that can be disfiguring. Psoriasis is also associated with cardiovascular disease and the metabolic syndrome, suggesting that like other T-cell driven disorders such as rheumatoid arthritis and systemic lupus erythematosus, psoriasis is an independent risk factor for atherothrombotic disease. Severe psoriasis is associated with an increased risk for mortality, largely attributable to cardiovascular death. Clearly, psoriasis is a disease with far reaching impact well beyond the skin.

This program will explore the clinical features of psoriatic skin and joint disease, associated comorbidities, and the evolving treatment paradigm for psoriatic disease.

This webcast was recorded live at the Conversations in Primary Care Live Virtual Symposium 2018 and is being used with the permission of the presenters.

Learning Objectives
After completing this program participants should be able to:
  1. Identify and describe the clinical features of psoriatic skin and joint disease
  2. Review and discuss associated comorbidities and emerging bio factors and their significance in the management of psoriatic disease
  3. Discuss the expanding and dynamically changing treatment paradigm for psoriasis and its related disorders
  4. Review and interpret up to date evidence-based clinical trial data and the latest treatments available for the management of psoriatic disease

How to obtain the CME Certificate

  1. Register for the course at www.naceonline.com
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education (which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Dr. Glick serves on the speaker bureau for SunPharma/Ranbaxy, Merz, LEO, Abbvie, Janssen, Celgene, Galderma, Lilly, and Novartis Pharmaceuticals Corporation. Dr. Glick is also a member of the advisory board for Lilly and TopMD stockholder.

Dr. Yamauchi serves as a consultant for AbbVie, Amgen, Celgene Corporation, Janssen-Ortho Inc., LEO Pharma, US, Novartis Pharmaceuticals Corporation, Pfizer Inc., and Regeneron. He serves as a speaker for AbbVie, Amgen, Celgene Corporation, Galderma USA, Janssen-Ortho Inc., LEO Pharma Inc., and Novartis Pharmaceuticals Corporation. Dr. Yamauchi is also a principal investigator for Amgen, Celgene Corporation, Dermira, Galderma USA, Janssen-Ortho Inc., LEO Pharma Inc., Lilly ICOS LLC, Medimmune, Novartis Pharmaceuticals Corporation, Pfizer Inc., Regeneron, and Sandoz, a Novartis company. He also serves on the advisory boards of Amgen, Dermira, and Lilly ICOS LLC.

Gregg Sherman, MD, Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Daniela Hiedra, BA, Activity Planning Committee, has no relationships to disclose.

Sandy Bihlmeyer, MEd, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose
Commercial Support
This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.